Information services provider Wolters Kluwer Health (WK Health), US, has announced that its Medi-Span solution has been expanded to include a new Patient Safety Programs File. The application enables health IT systems to rapidly identify drugs containing specific characteristics that require surveillance based on federal regulations.
Along with its ability to help facilitate compliance with government reporting requirements, the Patient Safety Programs File also supports the development of patient safety initiatives. It does this by incorporating drug indicators into the workflows of clinician end-users.
The application identifies drugs that require a Risk Evaluation and Mitigation Strategies (REMS) programme and includes a summary of the REMS programmes. This summary can be incorporated directly into the clinician's workflow to provide the type of information they need for the programme when at the point of care. The file can also include the associated Medication Guides as reported by the manufacturer in PDF and PCL5 formats.
Other supported indicators include Black Box Warnings (BBW) including text of warning in XML format, Medication Guide Requirements outside of REMS, Acetaminophen Ingredient, Pseudoephedrine Ingredient and Tall Man Drug Names.
By adding the Patient Safety Programs File to its Medi-Span drug database offerings, WK Health seeks to equip healthcare organisations with the automation needed to help rapidly pinpoint potential problem drugs, streamline compliance and achieve the highest level of patient safety.
